Eisai

Rediff.com » News » Eisai

News for Eisai

Business

Medical devices industry eyes Rs 70,000 cr investment in 5 years

The government is targeting 1,200 technical collaborations between Japanese companies and Indian investors for over Rs 42,000 crore, 200 joint ventures with overseas investors for Rs 14,000 crore,......

Eisai to invest $44 mn in India

Eisai Pharmaceuticals, the billion Japanese pharmaceuticals group, is planning to open a production and research unit in India next year.The group is expected to invest over yen 5 billion (close......

Markets ends flat; Sensex posts best monthly gain in over 4 years

The S&P BSE Sensex ended the session at 25,342, up 3 points while the Nifty50 closed at 7,738 points. Markets ended the last day of the financial year on a lacklustre note as traders rolled their......

Markets snap 6-day losing streak; Nifty ends above 8,050 amid volatility

The 30-share Sensex ended higher by 31 points at 26,591 and the 50-share Nifty gained 10 points at 8,061. The broader markets outperformed the benchmark indices- BSE Midcap and Smallcap......

Lupin launches generic GERD drug in the US market

Drug major Lupin said on Monday it has launched a generic version of Japan-headquartered Eisai Inc's Aciphex delayed-release tablets, used to treat gastroesophageal reflux disease, in the US......

Rediff News

Eisai

News for Eisai

Medical devices industry eyes Rs 70,000 cr investment in 5 years

Eisai to invest $44 mn in India

Markets ends flat; Sensex posts best monthly gain in over 4 years

Markets snap 6-day losing streak; Nifty ends above 8,050 amid volatility

Lupin launches generic GERD drug in the US market

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS